Reduced TILs or in our case reduced CD4 + T-cell numbers around the tumour could be a direct result of chemotherapy treatment [17, 27–30], but the association with reduced tumour cell content here suggests an already diminishing immune response in those tumours that are exquisitely sensitive to neo-adjuvant treatment. Here, CD4 is linked to neoplasm.